MediPrint™ Ophthalmics Announces Its SIGHT-2 Phase 2b Clinical Study with CBCC

CBCC Global Research looks forward to working with MediPrint Ophthalmics on this important study to help move #ophthalmic drug delivery forward. The #drugeluting contact lens platform is an important option for millions of patients.

We also congratulate MediPrint on the recent move and manufacturing scale-up.

Please see the press release issued by MediPrint for additional details: https://lnkd.in/djW7-GBh

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

News & Events

Latest News

MediPrint™ Ophthalmics Announces Its SIGHT-2 Phase 2b Clinical Study with CBCC

CBCC Global Research

CBCC Global Research